Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68462-672

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68462-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

Carton
NDC 68462-672-95 is a prescription product manufactured by Glenmark Pharmaceuticals Ltd in Goa, India. It is an extended-cycle tablet dispenser containing Levonorgestrel and Ethinyl Estradiol Tablets, USP in the strength of 15 mg/0.03 mg with a pack of 3 pouches, each containing 91 tablets. The usual dosage of this oral contraceptive is one tablet daily for 91 consecutive days in the following order: 84 blue tablets followed by 7 white inert tablets as prescribed. This product is intended to prevent pregnancy but does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Store the medication at 20° to 25°C (68° to 77°F); excursions permitted 10 15° to 30°C (59° to 86°F) and protect from light.*
FDA Label Image

Chart (Chart)

Chart (Chart)
This text describes different methods of birth control and their effectiveness rates, represented by the number of pregnancies per 100 women in one year. The text suggests that implants, injections, intrauterine devices, and sterilization are the most effective methods, with fewer than 1 pregnancy per 100 women in one year. Birth control pills, a skin patch, and a vaginal ring with hormones are also mentioned but with lower effectiveness rates. Additionally, condoms, diaphragms, spermicide, withdrawal, and avoiding sex during the most fertile days of the monthly cycle are mentioned but with higher effectiveness rates. Finally, the absence of birth control is also mentioned.*
FDA Label Image

Eestructure

FDA Label Image

Figure A

FDA Label Image

Figure B

FDA Label Image

Figure C

Figure C
This text provides a list of relevant studies examining the risk of breast cancer with the use of combined oral contraceptives. It includes the names of the studies, their authors, and their publication dates. The studies compare the risk of breast cancer in women who have used combined oral contraceptives versus those who have never used them. The text also includes an "Effect Estimate" chart, which is not readable.*
FDA Label Image

Figurea

FDA Label Image

Figureb

Figureb
Levonorgestrel and Ethinyl Estradiol Tablets is a medication classified under oral contraceptives. The text includes some unreadable characters that may contain relevant information.*
FDA Label Image

Figurec

Figurec
This text appears to be a label for Levonorgestrel and Ethinyl Estradiol Tablets, USP, which are used for contraception. The label includes the brand name "EE-Texil" and some technical information such as dosages and product codes.*
FDA Label Image

Levonorgestrel

FDA Label Image
FDA Label Image

Logo1

FDA Label Image

Logo2

FDA Label Image

Pouch

Pouch
This is a package insert for a medication called Levonorgestrel and Ethinyl Estradiol Tablets. The medication is intended for preventing pregnancy and does not protect against HIV or other sexually transmitted diseases. The package contains 91 tablets, 84 blue tablets containing 0.15 mg levonorgestrel USP and 0.03 mg cthinyl estradiol USP and 7 white inert tablets. The dosage is one tablet daily for 91 consecutive days. The medication should be stored at controlled room temperature and kept out of reach of children. It is manufactured by Glenmark Pharmaceuticals Inc., USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.